- Investing Ideas
- /
- Swedish Pharmaceuticals & Biotech Leverage Leaders
Swedish Pharmaceuticals & Biotech Leverage Leaders
Results
3
0 new
3 companies
Camurus
Market Cap: SEK 41.1b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 688.50
7D
-0.4%
1Y
23.7%
BioArctic
Market Cap: SEK 46.2b
Develops biological drugs for patients with central nervous system disorders in Sweden.
BIOA B
SEK 311.00
7D
-5.5%
1Y
42.9%
Swedish Orphan Biovitrum
Market Cap: SEK 118.0b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
SOBI
SEK 342.40
7D
3.3%
1Y
3.1%